Shu Chen
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025).
Journal: Blood science (Baltimore, Md.)
Published: May 22, 2025
Design and development of an aptamer targeting C-type lectin-like molecule-1 as a biomarker for acute myeloid leukemia: a SELEX approach.
Journal: Frontiers in bioengineering and biotechnology
Published: April 03, 2025
Pathogenesis of Haemophilia in 20 Women and Girls.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 21, 2025
An investigation of a hemophilia A female with heterozygous intron 22 inversion and skewed X chromosome inactivation.
Journal: Frontiers in genetics
Published: September 26, 2024
Downregulation of miR-182-5p by NFIB promotes NAD+ salvage synthesis in colorectal cancer by targeting NAMPT.
Journal: Communications biology
Published: January 06, 2023
Combining Low-Dose Rituximab and Bortezomib as Immunosuppressive Therapy for Acquired Hemophilia A: 6 Case Series.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: November 28, 2022
Geiparvarin Inhibits the Progression of Osteosarcoma by Down-regulating COX2 Expression.
Journal: Current cancer drug targets
Published: May 19, 2022
Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 20, 2022
HBx inhibits DNA sensing signaling pathway via ubiquitination and autophagy of cGAS.
Journal: Virology journal
Published: January 12, 2022
Geiparvarin Inhibits OS Metastasis through Upregulation of ANGPTL4 Expression by Inhibiting miRNA-3912-3p Expression.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: January 05, 2022
Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: October 27, 2021
Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma.
Journal: Frontiers in surgery
Published: July 14, 2021
Last Updated: 09/26/2026